Gene Jockeys

Life Science and the Rise of Biotech Enterprise

Nonfiction, Health & Well Being, Medical, Reference, History, Science & Nature, Science, Biological Sciences, Biology
Cover of the book Gene Jockeys by Nicolas Rasmussen, Johns Hopkins University Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Nicolas Rasmussen ISBN: 9781421413419
Publisher: Johns Hopkins University Press Publication: May 15, 2014
Imprint: Language: English
Author: Nicolas Rasmussen
ISBN: 9781421413419
Publisher: Johns Hopkins University Press
Publication: May 15, 2014
Imprint:
Language: English

The biotech arena emerged in the 1970s and 1980s, when molecular biology, one of the fastest-moving areas of basic science in the twentieth century, met the business world. Gene Jockeys is a detailed study of the biotech projects that led to five of the first ten recombinant DNA drugs to be approved for medical use in the United States: human insulin, human growth hormone, alpha interferon, erythropoietin, and tissue plasminogen activator.

Drawing on corporate documents obtained from patent litigation, as well as interviews with the ambitious biologists who called themselves gene jockeys, historian Nicolas Rasmussen chronicles the remarkable, and often secretive, work of the scientists who built a new domain between academia and the drug industry in the pursuit of intellectual rewards and big payouts. In contrast to some who critique the rise of biotechnology, Rasmussen contends that biotech was not a swindle, even if the public did pay a very high price for the development of what began as public scientific resources. Within the biotech enterprise, the work of corporate scientists went well beyond what biologists had already accomplished within universities, and it accelerated the medical use of the new drugs by several years.

In his technically detailed and readable narrative, Rasmussen focuses on the visible and often heavy hands that construct and maintain the markets in public goods like science. He looks closely at how science follows money, and vice versa, as researchers respond to the pressures and potential rewards of commercially viable innovations. In biotechnology, many of those engaged in crafting markets for genetically engineered drugs were biologists themselves who were in fact trying to do science.

This book captures that heady, fleeting moment when a biologist could expect to do great science through the private sector and be rewarded with both wealth and scientific acclaim.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The biotech arena emerged in the 1970s and 1980s, when molecular biology, one of the fastest-moving areas of basic science in the twentieth century, met the business world. Gene Jockeys is a detailed study of the biotech projects that led to five of the first ten recombinant DNA drugs to be approved for medical use in the United States: human insulin, human growth hormone, alpha interferon, erythropoietin, and tissue plasminogen activator.

Drawing on corporate documents obtained from patent litigation, as well as interviews with the ambitious biologists who called themselves gene jockeys, historian Nicolas Rasmussen chronicles the remarkable, and often secretive, work of the scientists who built a new domain between academia and the drug industry in the pursuit of intellectual rewards and big payouts. In contrast to some who critique the rise of biotechnology, Rasmussen contends that biotech was not a swindle, even if the public did pay a very high price for the development of what began as public scientific resources. Within the biotech enterprise, the work of corporate scientists went well beyond what biologists had already accomplished within universities, and it accelerated the medical use of the new drugs by several years.

In his technically detailed and readable narrative, Rasmussen focuses on the visible and often heavy hands that construct and maintain the markets in public goods like science. He looks closely at how science follows money, and vice versa, as researchers respond to the pressures and potential rewards of commercially viable innovations. In biotechnology, many of those engaged in crafting markets for genetically engineered drugs were biologists themselves who were in fact trying to do science.

This book captures that heady, fleeting moment when a biologist could expect to do great science through the private sector and be rewarded with both wealth and scientific acclaim.

More books from Johns Hopkins University Press

Cover of the book The Carbon Code by Nicolas Rasmussen
Cover of the book Understanding Anesthesia by Nicolas Rasmussen
Cover of the book Demographics and the Demand for Higher Education by Nicolas Rasmussen
Cover of the book John W. Garrett and the Baltimore and Ohio Railroad by Nicolas Rasmussen
Cover of the book Inventing Iron Man by Nicolas Rasmussen
Cover of the book Introduction to Abstract Algebra by Nicolas Rasmussen
Cover of the book Wealth and Disaster by Nicolas Rasmussen
Cover of the book Political Philosophy and the God of Abraham by Nicolas Rasmussen
Cover of the book Gliding for Gold by Nicolas Rasmussen
Cover of the book Stage Fright by Nicolas Rasmussen
Cover of the book The Inevitable Hour by Nicolas Rasmussen
Cover of the book Constructing Democratic Governance in Latin America by Nicolas Rasmussen
Cover of the book Stealing Cars by Nicolas Rasmussen
Cover of the book African American Faces of the Civil War by Nicolas Rasmussen
Cover of the book Red Modernism by Nicolas Rasmussen
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy